Area of research
Dermatology · Pathology and Forensic Medicine
Research interest
Research interests include Cutaneous lymphoproliferative disorders research, Lymphoma Diagnosis and Treatment, T-cell and Retrovirus Studies, and Fungal Infections and Studies.
Exploring the integration of patient-reported outcome measures in clinical practice: A cross-sectional survey of EORTC healthcare professionals
Preclinical <i>in vitro</i> and <i>in vivo</i> evidence for targeting CD74 as an effective treatment strategy for cutaneous T-cell lymphomas
Estrogen receptor β stimulation as a possible novel therapeutic target for cutaneous T-cell lymphoma
Extracorporeal photopheresis therapy rapidly changes the cytokine profile and tumor microenvironment in cutaneous T cell lymphoma
Haematogenous seeding in mycosis fungoides and Sézary syndrome: current evidence and clinical implications
The fifth edition of the WHO‐Classification – what is new for cutaneous lymphomas?
Health‐related quality of life and its influencing factors in patients with primary cutaneous B‐cell lymphomas: A multicentric study in 100 patients
Real-World Pattern-of-Care Analysis of Primary Cutaneous Lymphomas Radiation Therapy Among European Organisation for Research and Treatment of Cancer Members
Spontaneous regression of primary cutaneous diffuse large B‐cell lymphoma, leg type: A case series and review of the literature
Dimethyl fumarate and extracorporeal photopheresis combination-therapy synergize in inducing specific cell death and long-term remission in cutaneous T cell lymphoma
Evaluation of Sézary cell marker expression and cell death behaviour upon in vitro treatment by flow cytometry in Sézary syndrome patients
EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2023
Dimethyl fumarate treatment in relapsed and refractory cutaneous T-cell lymphoma: a multicenter phase 2 study
Deep Learning–Enabled Diagnosis of Liver Adenocarcinoma
Mogamulizumab Combined with Extracorporeal Photopheresis as a Novel Therapy in Erythrodermic Cutaneous T-cell Lymphoma
Identifying unmet needs and challenges in the definition of a plaque in mycosis fungoides: An EORTC‐CLTG/ISCL survey
Chronic spontaneous urticaria—status quo and future
S2k‐Guidelines – Cutaneous lymphomas (ICD10 C82 ‐ C86): Update 2021
Clinical, histopathological and prognostic features of primary cutaneous acral <scp>CD8</scp> <sup>+</sup> T‐cell lymphoma and other dermal <scp>CD8</scp> <sup>+</sup> cutaneous lymphoproliferations: results of an <scp>EORTC</scp> Cutaneous Lymphoma Group workshop*
S2k‐Leitlinie – Kutane Lymphome (ICD10 C82–C86): Update 2021
The optimal use of chlormethine gel for mycosis fungoides: An expert consensus from Germany, Austria and Switzerland (DACH region)
CCR4 in cutaneous T‐cell lymphoma: Therapeutic targeting of a pathogenic driver
Dimethyl fumarate (DMF) therapy in CTCL: results from a clinical phase II study
Understanding the function of CD30 in cutaneous T-cell lymphoma: implications for therapy and prognosis
Preclinical investigation of new targeted combination therapies in cutaneous T-cell lymphoma
Definition, aims, and implementation of GA<sup>2</sup>LEN/HAEi Angioedema Centers of Reference and Excellence
The importance of assessing blood tumour burden in cutaneous T‐cell lymphoma*
Combined inhibition of Bcl-2 and NFκB synergistically induces cell death in cutaneous T-cell lymphoma
Unizentrische, retrospektive Analyse der praktischen Durchführung der extrakorporalen Photopherese
Bilateral Inguinal Ulcerations as First Presentation of Acute Myeloid Leukaemia